OMERS ADMINISTRATION Corp Has $2.80 Million Position in Cencora, Inc. $COR

OMERS ADMINISTRATION Corp boosted its position in Cencora, Inc. (NYSE:COR) by 44.7% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,927 shares of the company’s stock after purchasing an additional 2,759 shares during the quarter. OMERS ADMINISTRATION Corp’s holdings in Cencora were worth $2,804,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in COR. Kemnay Advisory Services Inc. bought a new stake in Cencora in the 4th quarter valued at about $25,000. Oakworth Capital Inc. acquired a new position in shares of Cencora during the 4th quarter worth approximately $26,000. Elyxium Wealth LLC acquired a new position in shares of Cencora during the 4th quarter worth approximately $27,000. Archer Investment Corp increased its holdings in shares of Cencora by 134.3% during the fourth quarter. Archer Investment Corp now owns 82 shares of the company’s stock worth $28,000 after purchasing an additional 47 shares during the period. Finally, Motiv8 Investments LLC bought a new position in shares of Cencora during the fourth quarter worth approximately $29,000. 97.52% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

COR has been the subject of several recent research reports. Weiss Ratings cut Cencora from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, June 30th. Wells Fargo & Company lowered their price objective on Cencora from $429.00 to $331.00 and set an “overweight” rating on the stock in a research note on Monday, May 11th. William Blair began coverage on Cencora in a report on Tuesday, April 28th. They issued a “market perform” rating for the company. Citigroup cut their target price on Cencora from $405.00 to $355.00 and set a “buy” rating for the company in a research report on Thursday, May 7th. Finally, Bank of America increased their target price on Cencora from $280.00 to $285.00 and gave the stock a “neutral” rating in a report on Wednesday, June 24th. Eleven equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $367.75.

Cencora Stock Performance

NYSE COR opened at $320.05 on Wednesday. The firm’s 50 day simple moving average is $286.59 and its 200 day simple moving average is $315.90. The firm has a market capitalization of $62.27 billion, a price-to-earnings ratio of 24.54, a P/E/G ratio of 1.73 and a beta of 0.58. The company has a current ratio of 0.95, a quick ratio of 0.59 and a debt-to-equity ratio of 3.40. Cencora, Inc. has a 1 year low of $244.82 and a 1 year high of $377.54.

Cencora (NYSE:COR) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $4.75 EPS for the quarter, missing the consensus estimate of $4.82 by ($0.07). Cencora had a net margin of 0.78% and a return on equity of 135.20%. The firm had revenue of $78.36 billion for the quarter, compared to analyst estimates of $81.09 billion. During the same quarter in the prior year, the firm earned $4.42 earnings per share. The firm’s revenue for the quarter was up 3.9% on a year-over-year basis. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. As a group, research analysts expect that Cencora, Inc. will post 17.79 earnings per share for the current fiscal year.

Cencora Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Friday, May 15th were issued a dividend of $0.60 per share. The ex-dividend date of this dividend was Friday, May 15th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.7%. Cencora’s payout ratio is 18.40%.

Cencora declared that its board has approved a share repurchase program on Thursday, May 21st that authorizes the company to repurchase $2.00 billion in shares. This repurchase authorization authorizes the company to reacquire up to 3.9% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company’s management believes its shares are undervalued.

Insider Buying and Selling at Cencora

In other Cencora news, Director Lauren M. Tyler acquired 550 shares of the company’s stock in a transaction that occurred on Monday, June 22nd. The stock was acquired at an average cost of $270.23 per share, for a total transaction of $148,626.50. Following the transaction, the director directly owned 4,359 shares in the company, valued at $1,177,932.57. This represents a 14.44% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. 0.38% of the stock is currently owned by corporate insiders.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.